Data as of:
Price 02-03-26 16:00 ET,
Balance Sheet 2025-09-30,
Income Statement 2025-09-30,
Cash Flow 2025-09-30
Indicators
Dividend indicators
Value
Date
Pays Dividend
No
2-1-2026
Income indicators
Value
Date
EBITDA Positive
Yes
2-1-2026
Net Income Positive
Yes
2-1-2026
Avg CA Burn (Annual %)
2.02%
2-1-2026
Avg CA Burn (Quarterly %)
-9.43%
2-1-2026
Shares Outstanding Changes
Date
Shares Outstanding
Delta
2025-11-07
44,876,522
-1,057,729
2025-09-17
45,934,251
-49
2025-08-08
45,934,300
-909,300
Short Interest Changes
Latest short interest:
2,680,297 shares
(8.72% of float)
| Days to cover: 4.57
Date
Short Interest
Delta
Δ %
2026-02-03
2,680,297 shares
+0
+0.00%
2026-02-02
2,680,297 shares
+0
+0.00%
2026-01-30
2,680,297 shares
None
—
Interesting Volume Days
Volume/ratio use shares outstanding as of the event date (frozen).
Date
Volume
Shares Outstanding
Volume / Shares
Price
No interesting volume events
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.